Guest guest Posted March 31, 2007 Report Share Posted March 31, 2007 http://r.smartbrief.com/resp/gzrciFkDvLoQrnjvwJ New strategy brings patent win for Merck By changing a few words in the description of its osteoporosis treatment Fosamax, <http://r.smartbrief.com/resp/gzrciFkDvLoQrmXDkg>Merck has succeeded in regaining some patent control of the blockbuster drug. The patent had been invalidated by U.S. and European Union officials, but the European Patent Office accepted the reworded application and granted Merck a patent good until 2018. The rewording now simply reads that alendronate, the chemical name for Fosamax, is used to treat osteoporosis. <http://r.smartbrief.com/resp/gzrciFkDvLoQrnjvwJ>MSNBC/Financial Times (3/29) <http://r.smartbrief.com/resp/gzrciFkDvLoQsmKqlN> <http://r.smartbrief.com/resp/gzrciFkDvLoQsnLaxg> -------------------------------------------------------- Sheri Nakken, R.N., MA, Hahnemannian Homeopath Vaccination Information & Choice Network, Nevada City CA & Wales UK $$ Donations to help in the work - accepted by Paypal account earthmysteriestours@... voicemail US 530-740-0561 (go to http://www.paypal.com) or by mail Vaccines - http://www.nccn.net/~wwithin/vaccine.htm Vaccine Dangers On-Line course - http://www.nccn.net/~wwithin/vaccineclass.htm Reality of the Diseases & Treatment - http://www.nccn.net/~wwithin/vaccineclass.htm Homeopathy On-Line course - http://www.nccn.net/~wwithin/homeo.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.